Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality

Abstract

The use of ADT appears to be associated with an increased risk of death from cardiovascular causes in patients undergoing radical prostatectomy for localized prostate cancer.